TL;DR
OpenAI has officially launched ChatGPT Health to all United States users, integrating deeply with Apple Health, MyFitnessPal, and Function to turn passive personal health data into an active AI-driven assistant. This move immediately challenges established healthcare incumbents and sets a new regulatory precedent, as it is the first OpenAI product to achieve full HIPAA compliance.
What Happened
OpenAI opened the gates to its long-anticipated ChatGPT Health product for all US users on Thursday, July 23, 2026, marking the company's most aggressive pivot into regulated healthcare. Users can now upload lab results, describe symptoms, and grant the AI direct read-and-analyze access to years of biometric data from Apple Health, MyFitnessPal, and the comprehensive biomarker platform Function.
Key Facts
- OpenAI confirmed HIPAA compliance for ChatGPT Health, a first for the company that subjects it to federal patient privacy regulations.
- The product integrates with Apple Health, MyFitnessPal, and Function, allowing the AI to process longitudinal data such as heart rate variability, blood glucose, sleep patterns, and calorie intake.
- ChatGPT Health follows a 6-month closed beta involving approximately 50,000 patients and physicians from Mayo Clinic and Stanford Medicine.
- Users on the free tier receive limited access: 10 health-specific queries per month and basic data interpretation.
- ChatGPT Plus ($20/month) and Pro ($200/month) subscribers receive unlimited health queries, priority processing of medical documents, and the ability to upload DICOM images and PDF lab reports.
- OpenAI introduced a "Physician Review" toggle that, when enabled, routes AI-generated health insights to a board-certified doctor via a partnership with Ro and Teladoc Health for an additional $15 per review.
- Apple’s Chief Operating Officer Jeff Williams appeared alongside OpenAI executives to announce that Apple Health’s export
